Oxidative Stress and Inflammatory Biomarkers in Gaucher Disease
NCT02437396 · Status: RECRUITING · Type: OBSERVATIONAL · Enrollment: 34
Last updated 2026-03-19
Summary
The objective of this study is to evaluate oxidative stress and/or inflammation in patients with Gaucher disease type I using a series of biomarkers and correlate with measurements of currently used diagnostic biomarkers.
Conditions
- Gaucher Disease Type I
- Oxidative Stress
- Inflammation
Sponsors & Collaborators
- lead OTHER
Principal Investigators
-
Reena Kartha, PhD · University of Minnesota
Eligibility
- Min Age
- 18 Years
- Max Age
- 75 Years
- Sex
- ALL
- Healthy Volunteers
- No
Timeline & Regulatory
- Start
- 2015-10-31
- Primary Completion
- 2026-06-28
- Completion
- 2026-06-28
Countries
- United States
Study Locations
More Related Trials
-
Identification of Undiagnosed Gaucher Disease
NCT01716741 ·Status: UNKNOWN ·Phase: NA
-
Biomarkers Related to Bone in Pediatric Gaucher Disease
NCT06116071 ·Status: RECRUITING
-
Validating a New Severity Score System for Adults With Type 1 Gaucher Disease (GD1)
NCT01136304 ·Status: COMPLETED
-
SRT in Comparison to ERT on Immune Aspects and Bone Involvement in Gaucher Disease
NCT02605603 ·Status: UNKNOWN
-
Discovering New Biomarkers For Monitoring Disease Progression in Patients With Mucopolysaccharidosis IVA
NCT01733615 ·Status: TERMINATED
-
Study to Evaluate Blood Cell Lines From Patients With Gaucher Disease
NCT00351156 ·Status: COMPLETED
-
Antioxidant Signature in Adult Patients With Phenylketonuria
NCT02212288 ·Status: COMPLETED
-
A Multicenter Extension Study of Taliglucerase Alfa in Adult Subjects With Gaucher Disease
NCT01422187 ·Status: COMPLETED ·Phase: PHASE3
-
Studying Lipids as Potential Biomarkers in Patients With Fabry Disease
NCT05046379 ·Status: COMPLETED
-
The Natural History of Infantile Globoid Cell Leukodystrophy
NCT00983879 ·Status: COMPLETED
-
Longitudinal Studies to Identify Biomarkers for Sturge-Weber Syndrome
NCT04717427 ·Status: RECRUITING
-
Evaluation of the Long-term Safety, Pharmacodynamics, and Exploratory Efficacy of GZ/SAR402671 in Treatment-Naïve Adult Male Patients With Fabry Disease
NCT02489344 ·Status: COMPLETED ·Phase: PHASE2
-
Assessment Of Liver and Spleen Fibrosis in Patients With Gaucher Disease Using Fibroscan
NCT01898325 ·Status: UNKNOWN ·Phase: NA
-
Evaluation of Biochemical Markers and Clinical Investigation of Niemann-Pick Disease, Type C
NCT00344331 ·Status: RECRUITING
-
PKU Skin Stripping
NCT04368624 ·Status: COMPLETED
-
Endothelial Derived Hyperpolarization Factor and Vascular Control
NCT05176379 ·Status: RECRUITING ·Phase: PHASE4
-
Phase 2 Study of EPI-743 for Treatment of Rett Syndrome
NCT01822249 ·Status: COMPLETED ·Phase: PHASE2
-
AVTX-801 D-galactose Supplementation in SLC35A2-CDG
NCT05402384 ·Status: NOT_YET_RECRUITING ·Phase: PHASE2
-
Investigations Into ISCU Myopathy or Iron Sulfur Scaffold U Protein Myopathy
NCT01547767 ·Status: COMPLETED
-
Understanding Fabry Disease Therapy Choices Through the Eyes of the Patients
NCT04804566 ·Status: COMPLETED
-
Long Term Follow-up on Menkes Disease Patients
NCT04337684 ·Status: ACTIVE_NOT_RECRUITING
-
A Gene Therapy Study in Patients With Gaucher Disease Type 1
NCT05324943 ·Status: COMPLETED ·Phase: PHASE1
-
Phase I Study of Retrovirally Mediated Transfer of the Human Glucocerebrosidase Gene Into Peripheral Blood Stem Cells for Autologous Transplantation in Patients With Type I Gaucher Disease
NCT00004294 ·Status: COMPLETED ·Phase: PHASE1
-
Efficacy and Safety Study of Protein C Concentrate in Subjects With Severe Congenital Protein C Deficiency
NCT00157118 ·Status: COMPLETED ·Phase: PHASE2/PHASE3
-
A Study to Evaluate and Characterize the Effect of Pharmacological Chemicals on Blood From Patients With Gaucher Disease
NCT00465062 ·Status: COMPLETED